How should we treat a patient with early Parkinson's disease?
about
Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-enProspective cohort study of impulse control disorders in Parkinson's disease.Rapid onset of efficacy of rasagiline in early Parkinson's disease.Multi-Drug-Loaded Microcapsules with Controlled Release for Management of Parkinson's Disease.
P2860
How should we treat a patient with early Parkinson's disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How should we treat a patient with early Parkinson's disease?
@en
How should we treat a patient with early Parkinson's disease?
@nl
type
label
How should we treat a patient with early Parkinson's disease?
@en
How should we treat a patient with early Parkinson's disease?
@nl
prefLabel
How should we treat a patient with early Parkinson's disease?
@en
How should we treat a patient with early Parkinson's disease?
@nl
P2860
P1476
How should we treat a patient with early Parkinson's disease?
@en
P2093
S Konitsiotis
P2860
P304
P356
10.1111/J.1742-1241.2010.02371.X
P577
2010-08-01T00:00:00Z